Bang H Hoang
Overview
Explore the profile of Bang H Hoang including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
60
Citations
1683
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Goker B, Wang J, Marsh D, Zhang R, Lo Y, Fox J, et al.
J Bone Joint Surg Am
. 2025 Feb;
PMID: 39977531
Background: Minimally invasive techniques such as percutaneous screw fixation have previously been shown to be mostly successful for pain relief and functional improvement in patients with pelvic metastases. In this...
2.
Wang J, Zhao Z, Liang H, Zhang R, Liu X, Zhang J, et al.
Front Bioeng Biotechnol
. 2024 Aug;
12:1404937.
PMID: 39135949
Background: The percutaneous screw reconstruction technique, known as the "Tripod Technique," has demonstrated favorable clinical outcomes in the management of metastatic periacetabular lesions, as evidenced by our prior investigations and...
3.
Zhao Z, Niu J, Wang J, Zhang R, Liang H, Ma Y, et al.
J Cell Mol Med
. 2024 Jul;
28(14):e18541.
PMID: 39046429
Synovial sarcoma (SS) is an aggressive soft tissue sarcoma with poor prognosis due to late recurrence and metastasis. Metastasis is an important prognostic factor of SS. This study aimed to...
4.
Wang J, Ferrena A, Zhang R, Singh S, Viscarret V, Al-Harden W, et al.
Oncogene
. 2024 Feb;
43(13):962-975.
PMID: 38355807
Osteosarcoma(OS) is a highly aggressive bone cancer for which treatment has remained essentially unchanged for decades. Although OS is characterized by extensive genomic heterogeneity and instability, RB1 and TP53 have...
5.
Ferrena A, Wang J, Zhang R, Karadal-Ferrena B, Al-Hardan W, Singh S, et al.
Mol Cancer Ther
. 2023 Oct;
23(2):223-234.
PMID: 37871911
Osteosarcoma is an aggressive bone malignancy with a poor prognosis. One putative proto-oncogene in osteosarcoma is SKP2, encoding a substrate recognition factor of the SCF E3 ubiquitin ligase. We previously...
6.
Yang R, Falk A, Hoang B, Geller D
Instr Course Lect
. 2022 Mar;
71:221-230.
PMID: 35254785
There are an increasing number of patients who present with metastatic bone disease as the survival of patients with cancer improves in recent decades. The pelvis is the second most...
7.
Zvi Y, Ugur E, Batko B, Gill J, Roth M, Gorlick R, et al.
Sarcoma
. 2021 Feb;
2021:8324348.
PMID: 33603563
Background: Six cell surface receptors, human epidermal growth factor receptor-2 (Her-2), platelet-derived growth factor receptor- (PDGFR-), insulin-like growth factor-1 receptor (IGF-1R), insulin receptor (IR), c-Met, and vascular endothelial growth factor...
8.
Wang J, Aldahamsheh O, Ferrena A, Borjihan H, Singla A, Yaguare S, et al.
Ann N Y Acad Sci
. 2021 Feb;
1490(1):90-104.
PMID: 33594717
Osteosarcoma is a highly aggressive malignancy for which treatment has remained essentially unchanged for years. Our previous studies found that the F-box protein SKP2 is overexpressed in osteosarcoma, acting as...
9.
Geller D, Levine N, Hoang B, Yang R, Weiser D, Morris J, et al.
JCO Precis Oncol
. 2020 Sep;
3.
PMID: 32914027
No abstract available.
10.
Peterson H, Tank A, Geller D, Yang R, Gorlick R, Hoang B, et al.
J Biomed Opt
. 2020 Aug;
25(8):1-17.
PMID: 32790252
Significance: Diffuse optical spectroscopic imaging (DOSI) measures quantitative functional and molecular information in thick tissue in a noninvasive manner using near-infrared light. DOSI may be useful for diagnosis and prognosis...